Supplements for heart health (50+)
Cardiovascular supplement adjuncts for adults over 50 — supports for the medication and lifestyle foundation that actually carries the outcome data.
The heart-health-50+ stack — rationale by ingredient
Omega-3 EPA/DHA 1–2 g/day (or prescription icosapent ethyl 4 g/day if indicated)
Modest LDL-neutral triglyceride reduction and improved omega-3 index. REDUCE-IT data supports prescription icosapent ethyl (Vascepa) in secondary CV prevention with elevated triglycerides. Over-the-counter fish oil at 1–2 g/day is a reasonable general-CV adjunct. High-dose (≥1.8 g/day) carries an atrial fibrillation signal — coordinate with cardiology.
Vitamin D3 to a 30–50 ng/mL 25-OH-D target
Endothelial function and blood pressure trials are mixed on overall CV outcomes; correction of deficiency is the appropriate target rather than blanket supplementation. Test 25-OH-D; supplement to target.
CoQ10 (Ubiquinol) 100–200 mg/day with fat, for statin users
Statins deplete CoQ10. Symptomatic statin-associated myalgia in some users may improve with CoQ10 supplementation; the systematic review evidence is mixed but the mechanism is plausible and tolerance is excellent. Ubiquinol form preferred for adults over 40. The Q-SYMBIO trial showed mortality benefit at 300 mg/day in heart failure with reduced ejection fraction — a specific indication with strong evidence.
Magnesium glycinate 200–400 mg elemental in evening
Mild blood pressure reduction (~3 mmHg systolic), arrhythmia protection in deficiency, and sleep support. Avoid in eGFR <30; loose stools at higher doses. Form choice matters — glycinate or malate, not oxide.
Psyllium 5–10 g/day
Soluble fibre — directly binds bile acids, reduces LDL by 3–7%, modest glycemic improvement. FDA health-claim-eligible. Start at 3.5 g once daily with adequate water; titrate over 2 weeks. Pairs with statins; doesn't replace.
Dietary nitrate from beetroot 400–800 mg/day (or 300–600 mL juice)
Modest systolic BP reduction (~3–4 mmHg in hypertensive adults). Endurance-performance benefit if you're still exercising hard. Avoid antibacterial mouthwash (kills the oral bacteria needed for nitrate-to-nitrite conversion). Note: do not rely on for hypertension management — discuss with cardiologist.
Aged garlic extract (Kyolic) 600–1200 mg/day
Larger trial evidence than fresh garlic; modest BP and lipid effects; some signal on coronary artery calcium progression. Discuss with prescriber if on anticoagulants (mild antiplatelet effect).
Vitamin K2 (MK-7) 100–180 mcg/day
Direction calcium into bone and away from arteries; Rotterdam Study and follow-on observational data support; trial-level mortality endpoints are absent. AVOID if on warfarin (directly antagonises) without prescriber coordination.
What to skip
- Red yeast rice without prescriber supervision — contains monacolin K (lovastatin); produces a statin's effect without standardised dosing or labelling. Adverse effects similar to statins. Better to take a labelled statin if indicated.
- Niacin (high-dose for HDL) — AIM-HIGH and HPS2-THRIVE trials did not show clinical benefit; meaningful side effect burden (flushing, glucose elevation, hepatotoxicity). Skip outside specific indications.
- Omega-3-6-9 blends — diluted EPA/DHA; consumers buy a less concentrated and lower-dose product than intended. Buy EPA/DHA or icosapent ethyl directly.
- "Cholesterol support" supplements with proprietary blends — sub-therapeutic doses of effective ingredients; pay for psyllium, plant sterols, or red yeast rice directly.
- Folic acid as cardiovascular prevention — homocysteine reduction did not translate to cardiovascular event reduction in major trials.
- Multivitamins as cardiovascular prevention — major trials (PHS II, COSMOS) show neutral overall cardiovascular outcomes.
- Vitamin E megadose — increased all-cause mortality signal at high doses; modest doses of mixed tocopherols are fine.
- Calcium supplements without specific indication — some observational data suggests cardiovascular risk; favor dietary calcium and supplement only to fill specific gaps under prescriber guidance.
The base layer that no supplement matches
The largest cardiovascular wins in adults over 50 come from: regular aerobic exercise (150+ min/week moderate, plus 2× weekly resistance), Mediterranean or DASH dietary pattern, weight management toward BMI 22–27, blood pressure control to <130/80 (often requiring 1–3 prescription agents), LDL targets per ASCVD risk (often statin-based), HbA1c management if pre-diabetic or diabetic, smoking cessation, sleep apnea identification and treatment, and stress management. Annual primary care and ASCVD risk recalculation. Supplements are adjunct, not foundation.
Sources
- Bhatt DL, et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia (REDUCE-IT). N Engl J Med. 2019;380(1):11–22. PMID: 30415628
- Mortensen SA, et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure (Q-SYMBIO). JACC Heart Fail. 2014;2(6):641–649. PMID: 25282031
- Manson JE, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease (VITAL). N Engl J Med. 2019;380(1):33–44. PMID: 30415629
- Webb AJ, et al. Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension. 2008;51(3):784–790. PMID: 18250365
- Brown L, et al. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr. 1999;69(1):30–42. PMID: 9925120
- Ried K, et al. Effect of garlic on serum lipids: an updated meta-analysis. Nutr Rev. 2013;71(5):282–299. PMID: 23590705
- O'Keefe EL, et al. Atrial fibrillation and omega-3 fatty acids: a review of dose, comorbidity, and risk. Eur J Prev Cardiol. 2024 (PMID 39617283).